Optilume urethral dilation

Author: bqqy

August undefined, 2024

WebApr 10, 2024 · 1 BACKGROUND. A urethral stricture is the narrowing of the urethra, the tube that carries urine out of the body. 1 Urethral strictures have multiple aetiologies, including an infection that leads to urethral inflammation and trauma to the urethra as a result of injury. A urethral stricture can occur to any individual; however, they are most likely to occur in … WebThe Optilume drug-coated balloon represents a step forward in the endoscopic management of urethral strictures. The drug-coated balloon may offer an intermediate step prior to repeated dilations, urethrostomies, or urethroplasty. This treatment modality is a promising alternative to current endoscopic management and an option for patients that ...

Optilume® Urethral Drug Coated Balloon - Laborie

WebOptilume (Urotronic) is a drug-coated balloon indicated for treating anterior urethral strictures. The technology combines balloon dilation, to expand or widen the strictured … Web+ Optilume is a small, cylindrical balloon coated in medication engineered to simultaneously open the urethra and slow or stop stricture regrowth. + Similar balloons have successfully … high friction surface treatment bid

A Drug-Coated Balloon Treatment for Urethral Stricture Disease

The Optilume® Urethral Drug Coated Balloon (DCB) uses a drug-coated balloon attached to the end of a urethral catheter to expand the urethra, that may be abnormally narrowed (stricture). The balloon is coated on its outer surface with paclitaxel, a drug that may help preserve the expansion of the … See more A physician inserts the balloon catheter into the portion of the urethra that has a stricture. The balloon is inflated to expand the urethra which will allow improved urine flow. During the balloon expansion, paclitaxel is … See more The Optilume® DCB should not be used in patients who have: 1. A known hypersensitivity to the drug paclitaxel or structurally related compounds. 2. Urologic implants such as penile implants or artificial urinary … See more The Optilume® DCB is used to treat patients, primarily adult males, with urinary symptoms associated with urethral stricture. See more Use of the Optilume® DCB is intended to improve urinary flow rate through at least six months in patients with urethral stricture. See more WebThe Optilume (Urotronic, Plymouth, MN, USA) drug-coated balloon, Figure 1, is a minimally invasive urethral stricture treatment developed in response to demand for improved … WebMar 17, 2024 · Also in December, the US Food and Drug Administration approved the Optilume® Device for the treatment of male urethral strictures. The device uses a drug coated balloon to dilate the urethra at the site of the stricture. high friction surface treatment uk

Urethral Stricture Treatments & Information

Optilume urethral dilation

(PDF) Optilume® drug-coated balloon dilation in complex female urethral …

WebJan 30, 2024 · BPH Prostatic DCB treatment – The Optilume BPH Prostatic DCB Dilation Catheter System should be prepared per the Instructions for Use (IFU). Drug: Paclitaxel paclitaxel will release to adjacent tissue after the balloon inflated in the urethra Arms, Groups and Cohorts Experimental: Optilume™ BPH Prostatic DCB Dilation Catheter WebDec 1, 2024 · The Optilume™ drug-coated balloon, developed by Urotronic, based in Plymouth, MN, offers a minimally-invasive treatment option for men suffering from urinary tract conditions like benign prostatic hyperplasia (BPH), urethral and ureteral strictures, and bladder neck contractures.

Did you know?

WebNov 8, 2024 · Optilume was approved by the FDA in December 2024 for the treatment of men with urethral strictures. The AMA has issued a new Category 1 CPT Code (5X000) … WebFeb 22, 2024 · Brief Summary: The ROBUST IV study is designed to collect and better understand "real-world" outcomes for men undergoing urethral dilation using the Optilume Drug Coated Balloon (DCB) for treatment of urethral stricture. Study Design Go to Resource links provided by the National Library of Medicine MedlinePlus related topics: Medicines

WebMar 1, 2024 · We describe the first Optilume® urethral drug-coated balloon dilation for female urethral stricture disease involving the sphincter. After six months follow-up the … WebUrethral stricture is a fairly common men’s health problem that has been documented since ancient times. Unfortunately, the treatments for it don’t always prevent recurrence, for what can become a debilitating condition. …

WebFeb 6, 2024 · The objective of the study is to evaluate the safety and efficacy of the Optilume™ BPH Prostatic Drug Coated Balloon Dilation Catheter System in the treatment … WebDec 1, 2024 · We describe the first Optilume® urethral drug-coated balloon dilation for female urethral stricture disease involving the sphincter. After six months follow-up the …

WebApr 12, 2024 · Optilume is the world’s first Drug Coated Balloon approved by the FDA to treat patients with Urethral Strictures. The Optilume Urethral Drug Coated Balloon technology simultaneously dilates and delivers an anti-proliferative medicine to the urethral stricture.

WebMar 1, 2024 · Optilume ® combines balloon dilation of the urethral stricture with the delivery of an anti-proliferative drug to prevent recurrence of the blockage. The minimally invasive technology is expected to have a significant impact in the urological community, offering a new treatment option for urethral strictures that traditionally would require ... howick mutual insuranceWebAug 31, 2024 · Urethroplasty is an open surgical procedure performed under general anaesthesia. The scar tissue is cut away and the urethra is re-joined, or a tissue graft (from cheek lining) is used to widen the scarred urethra. Patients are catheterised for several weeks after surgery. howick nedbank branchWebIntroduction: Mechanical balloon dilation and direct visualization internal urethrotomy (DVIU) are the most widely used treatments for urethral stricture disease in the U.S., but recurrence rates are high, especially after re-treatment. This study investigates the safety and efficacy of the Optilume™ paclitaxel-coated balloon for the treatment of recurrent strictures. howick mutual insurance winghamWebDec 22, 2024 · We describe the first Optilume® urethral drug-coated balloon dilation for female urethral stricture disease involving the sphincter. After six months follow-up the … high friendship evolutionsWebMay 6, 2024 · Here, we report the 3-year results of the ROBUST I trial, which evaluated the safety and efficacy of the Optilume ® drug coated balloon (DCB) in men with recurrent urethral strictures. Methods: Adult men with recurrent bulbar urethral strictures ≤2 cm in length and 1-4 prior endoscopic interventions were treated with the Optilume DCB. howick northern lightsWebA Breakthrough Treatment for Urethral Stricture Disease. For patients who have failed prior endoscopic management, today there is Optilume® — a breakthrough urethral drug-coated balloon treatment that dilates the urethral lumen and delivers paclitaxel directly to the stricture, significantly reducing the incidence of stricture recurrence.² howick mutual insurance companyWebThe Optilume procedure is similar to the traditional method of mechanical dilatation of the urethra, making it easier to perform. The dynamic balloon expands in the tissues, creating microcracks that promote absorption of the drug around the circumference. The hydrophilic coating of the capsule promotes rapid release of the paclitaxel drug. high friendship